These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3428720)

  • 1. Factor VII in subjects at risk for thromboembolism: activation or increased synthesis?
    Orlando M; Leri O; Macioce G; Mattia G; Ferri GM
    Haemostasis; 1987; 17(6):340-3. PubMed ID: 3428720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolism in congenital factor VII deficiency.
    Shifter T; Machtey I; Creter D
    Acta Haematol; 1984; 71(1):60-2. PubMed ID: 6419528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme immunoassay (ELISA) for the quantitation of human factor VII.
    Boyer C; Wolf M; Rothschild C; Migaud M; Amiral J; Mannucci PM; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Dec; 56(3):250-5. PubMed ID: 2436328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
    Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
    Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease].
    Kario K; Matsuo T; Miyata T
    Rinsho Byori; 1995 Dec; 43(12):1201-8. PubMed ID: 8569029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients.
    Bruckert E; Ankri A; Jung M; Turpin G; De Gennes JL
    Eur J Med; 1993; 2(8):461-5. PubMed ID: 8258046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay.
    Tirindelli MC; Mariani G; Mazzucconi MG; Iacopino G; Carbonaro M; Ghirardini A; Motta M; Mandelli F
    Am J Hematol; 1987 Dec; 26(4):313-21. PubMed ID: 2961255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.
    Nordøy A; Illingworth DR; Connor WE; Goodnight S
    Haemostasis; 1990; 20(2):65-72. PubMed ID: 2347517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor VII and cardiovascular risk in obese subjects].
    Craveri A; Tornaghi G; Ranieri R; Paganardi L; Torti P; Marelli F; Moroni GA
    Ann Ital Med Int; 1990; 5(2):118-20. PubMed ID: 2248859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation factor VII levels in uremic patients and theirs influence factors].
    Fang J; Xia LH; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):730-2. PubMed ID: 15631649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VII activity state in coronary artery disease.
    Hoffman C; Shah A; Sodums M; Hultin MB
    J Lab Clin Med; 1988 Apr; 111(4):475-81. PubMed ID: 3351380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ELISA method for the determination of factor VII antigen].
    Jorquera JI; Aznar JA; Monteagudo J; Montoro JM; Casaña P; Pascual I; Bañuls E; Curats R; Llopis F
    Sangre (Barc); 1989 Dec; 34(6):514-7. PubMed ID: 2629128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay of factor VII antigen by enzyme-linked immunosorbent assay (ELISA)].
    Takamiya O
    Rinsho Byori; 1991 Apr; 39(4):437-41. PubMed ID: 2051627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activation of factor VII as a global marker of thrombophilic conditions].
    Barkagan ZS; Eremin GF; Mazyrko AV; Tamarin IV
    Kardiologiia; 1989 Jun; 29(6):121-5. PubMed ID: 2674517
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease].
    Friesewinkel O; Marbet GA; Ritz R
    Schweiz Med Wochenschr; 1993 Jan; 123(3):82-4. PubMed ID: 8426952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherothrombotic risk factor clustering in healthy male relatives of male patients with intermittent claudication.
    Parry DJ; Grant PJ; Scott DJ
    J Vasc Surg; 2004 Nov; 40(5):891-8. PubMed ID: 15557902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.